A Case of Lung Cancer with Pulmonary and Pleural Sarcoidosis
Takahiro Fukui(Tachikawa Hospital), Hidefumi Koh(Tachikawa Hospital), Junko Kagyo(Kawasaki Municipal Hospital), Yohei Funatsu(Keio University), Arifumi Iwamaru(Tachikawa Hospital), Masato Asaoka(Tachikawa Hospital), Tetsuo Tani(Keio University), Tatsuya Yamamoto(Tachikawa Hospital), Keeya Sunata(Keio University)
The Japanese Journal of Sarcoidosis and Other Granulomatous Disorders
October 1, 2019
Cited by 0
Related Papers
<i>In vitro</i> modeling to determine mutation specificity of EGFR tyrosine kinase inhibitors against clinically relevant <i>EGFR</i> mutants in non-small-cell lung cancer
|Oncotarget|2015|159
MPS1 inhibition primes immunogenicity of KRAS-LKB1 mutant lung cancer
|Cancer Cell|2022|101
<i>TREX1</i> Inactivation Unleashes Cancer Cell STING–Interferon Signaling and Promotes Antitumor Immunity
|Cancer Discovery|2024|98
Activation of Tumor-Cell STING Primes NK-Cell Therapy
|Cancer Immunology Research|2022|88
Overcoming EGFR Bypass Signal-Induced Acquired Resistance to ALK Tyrosine Kinase Inhibitors in ALK-Translocated Lung Cancer
|Molecular Cancer Research|2016|73